S&P 500
5,895.79
-0.3%
-$15.90
DJI
42,064.11
-0.5%
-$205.96
NASDAQ
19,109.76
-0.0%
-$4.01
Bitcoin
104,166.00
-0.1%
-144.90
AAPL
$201.22
+0.2%
+$0.37
AMZN
$204.54
-0.2%
-$0.47
GOOG
$169.86
-1.7%
-$2.99
META
$654.04
+1.0%
+$6.55
MSFT
$460.81
+0.1%
+$0.45
NVDA
$136.89
+1.3%
+$1.76
TSLA
$342.70
-1.1%
-$3.76
Champions Oncology (NASDAQ: CSBR)
$5.99
(2.0%)
$0.12
Price as of June 2, 2025, 9:32 a.m. ET
Champions Oncology Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Champions Oncology Company Info
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.